For Gavi transitioning countries, the LNCT platform offers the opportunity to share transition planning and implementation experience, work together to solve common problems, and add to a global knowledge base of tools and approaches that contribute to successful transition. Learn more about the LNCT platform here
Costs incurred by health programs for activities conducted above the front-line facility or community setting, referred to in this report as costs above the point of service delivery (ASD), constitute a substantial share of health program spending. This landscape summarizes the current state of knowledge and avenues for future inquiry and development. Read more here
Over the 5-year period ending in 2018, 16 countries with a combined birth cohort of over 6 million infants requiring life-saving immunizations are scheduled to transition (graduate) from outside financial and technical support for a number of their essential vaccines. Read more about early experiences from GAVI graduating countries here
This short report revealed community members' demographics, location and area of work, the projects they work on, the identified public resource, and current needs in methodological guide.
In the October 2017 Newsletter Issue, Dr. Brenzel thanks and welcomes the members of the Immunization Economics Community of Practice. Read her welcome letter here.
Dr Orin Levine: "Virtually every child in the world can access a Coca-Cola, yet globally, one in every seven children is still excluded from vaccines. In Africa, one in five go unvaccinated." Read more here
TVEE launched the first workshops of the series in Johannesburg, South Africa and Kampala, Uganda. The workshop series focuses on capacity building in applied vaccine economics, cost-effectiveness and finance. Read more here.
Using a standardised micro-costing tool, a new study presents the cost drivers of HPV vaccine delivery in low income countries and identifies optimal strategies to reduce costs without adversely impacting coverage. Read more here.
Your participation in this survey is crucial in helping us develop the evidence and resources to further the field of Immunization Economics. This survey should take around 20 minutes to complete. Thank you very much for your support. Take the survey here
National governments require economic data on burden of influenza disease, vaccine cost effectiveness , and projected implementation costs. The WHO has developed a value chain of economic analysis tools to cover this need. Read more here
There are few published Budget Impact Analyses (BIAs) compared with cost-effectiveness analyses (CEAs). This study proposes a framework to facilitate the uptake of budget impact of vaccines through CEA information in LMICs. Read more here.
A two-day Methods and Case Studies workshop in Boston seek to develop reference case guidelines for benefit-cost analysis in global health and development. Discussants include Larry Summers, Sue Goldie, and Dean Jamison. Read more here
Health Policy & Planning podcast discusses the importance in understanding detailed cost structure, its relationship with efficiency, and implications for health policy and future planning in immunization programs. Listen to podcast here.
Research helps stakeholders in Bangladesh and other countries make more informed decisions about the true economic burden of childhood diseases and better evaluate investments in vaccines. Read more here
Research teams & policymakers from Indonesia, Tanzania & Vietnam met in Hanoi to discuss costing study designs & cross cutting methods issues for the ICAN project - working towards sustainable immunization financing. Read more here
The Reference Case provides a guide to ensuring that the process of cost estimation is transparent and clear, enhancing the interpretation and use of quality cost data for decision making. See more here.
Health Policy and Planning blogpost examines how detailed understanding of the cost structure of immunization programs can inform policy. Read more here.
Focused on capacity building in applied vaccine economics, cost-effectiveness and finance, TVEE targets audience who are current decision-makers in EPI programs, NiTAGs and partners in GAVI eligible countries. Watch video here
The Value of Vaccination Research Network (VoVRN) is pleased to announce the initiation of a grant-making cycle to fund research on the broader social and economic impacts of vaccination (BSEIV) due Aug 4 2017. See instructions here.